ALFA Filings
Every announcement, straight from the exchange
Every SMS Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
SMS Pharmaceuticals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
SMS Pharmaceuticals disclosed two market sell trades by Designated Person NVV Satyanarayana totalling ₹0.14 Crore. The PIT Reg 7(2) intimation involves a non-promoter designated person.
SMS Pharmaceuticals Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent confirmed the dematerialization and cancellation of security certificates. This is a routine administrative filing with no material financial impact.